Leng L - Search Results

1

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity.

Teismann P, Sathe K, Bierhaus A, Leng L, Martin HL, Bucala R, Weigle B, Nawroth PP, Schulz JB. Teismann P, et al. Among authors: leng l. Neurobiol Aging. 2012 Oct;33(10):2478-90. doi: 10.1016/j.neurobiolaging.2011.12.006. Epub 2012 Jan 9. Neurobiol Aging. 2012. PMID: 22227007 Free PMC article.

2

Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity.

Sun C, Li H, Leng L, Raizada MK, Bucala R, Sumners C. Sun C, et al. Among authors: leng l. J Neurosci. 2004 Nov 3;24(44):9944-52. doi: 10.1523/JNEUROSCI.2856-04.2004. J Neurosci. 2004. PMID: 15525779 Free PMC article.

3

Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.

Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J. Lue H, et al. Among authors: leng l. Cell Signal. 2006 May;18(5):688-703. doi: 10.1016/j.cellsig.2005.06.013. Epub 2005 Aug 24. Cell Signal. 2006. PMID: 16122907

4

Macrophage migration inhibitory factor increases neuronal delayed rectifier K+ current.

Matsuura T, Sun C, Leng L, Kapurniotu A, Bernhagen J, Bucala R, Martynyuk AE, Sumners C. Matsuura T, et al. Among authors: leng l. J Neurophysiol. 2006 Feb;95(2):1042-8. doi: 10.1152/jn.00499.2005. Epub 2005 Nov 2. J Neurophysiol. 2006. PMID: 16267117 Free article.

5

Macrophage migration inhibitory factor.

Leng L, Bucala R. Leng L, et al. Crit Care Med. 2005 Dec;33(12 Suppl):S475-7. doi: 10.1097/01.ccm.0000191278.04636.d8. Crit Care Med. 2005. PMID: 16340426 Review. No abstract available.

6

Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor.

Leng L, Bucala R. Leng L, et al. Cell Res. 2006 Feb;16(2):162-8. doi: 10.1038/sj.cr.7310022. Cell Res. 2006. PMID: 16474429 Review.

7

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Tan KC, et al. Among authors: leng l. Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13. Diabetologia. 2006. PMID: 16969649

8

Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.

Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL. Meyer-Siegler KL, et al. Among authors: leng l. J Immunol. 2006 Dec 15;177(12):8730-9. doi: 10.4049/jimmunol.177.12.8730. J Immunol. 2006. PMID: 17142775

9

Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y, Leng L, Bucala R. Tan KC, et al. Among authors: leng l. J Lipid Res. 2008 Jul;49(7):1438-44. doi: 10.1194/jlr.M700551-JLR200. Epub 2008 Apr 12. J Lipid Res. 2008. PMID: 18408244 Free article.

10

The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.

El-Turk F, Cascella M, Ouertatani-Sakouhi H, Narayanan RL, Leng L, Bucala R, Zweckstetter M, Rothlisberger U, Lashuel HA. El-Turk F, et al. Among authors: leng l. Biochemistry. 2008 Oct 7;47(40):10740-56. doi: 10.1021/bi800603x. Epub 2008 Sep 17. Biochemistry. 2008. PMID: 18795803 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

744 results

Search Page

Filters